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ADP-ribosylation ofprotcins by the enzymatic transrcr of ADP-ribose from NAD has been implicated in 3 number of biological processes. We 
report that inhibitors oFADP-ribosylation, most notably the novel inhibitor orarginine speciticcellular mona(ADP-ribosyl) transferase, nleru-iado- 
bcnzylgunnidinc (MIBG) 3s well as nicotintimidc, L-arginine methyl ester (LAME) and gunnyltyramine, inhibit histamine-induced cndothclial 
production of inositol phosphates, release of arnchidonic acid and production or prostacyclin (PGIZ). Those same responses were unal’fected by 
MIBG when triggered by thrombin or lcukotricno C,. These findings suggest that ADP-ribasylation seizes a role in histamine-induced production 
of prostacyclin and imply differercnccs in transduction pathways employed by the dit%rent agonists. 
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1. INTRODUCTION 
ADP-ribosplation, i.e. posttranslntional modification 
of proteins by the enzymatic transfer of ADP-ribose 
from NAD resulting in alteration of the functional 
properties of the respective proteins has been implicated 
in a number of biological processes [1,2]. ADP-ri- 
bosyltransferase activity has been demonstrated in var- 
ious tissues and cells from many different species [2,3]. 
Furthermore, glycohydrolases capable of removing 
ADP-ribose from acceptor proteins have also been de- 
scribed in eukaryotic cells [2,4]. However, in most in- 
stances little is known about the physiological role of 
endogenous ADP-ribosylation and investigations have 
been hampered by the inability to introduce labeled 
NAD into cells. Recently BrUne and co-workers [5] were 
able to demonstrate agonist-induced ADP-ribosylation 
of a specific cytosolic 42-kDa protein in platelets and 
suggested that inhibition and stimulation of platelet re- 
sponses are closely related to the ADP-ribosylation of 
different proteins. Smets and co-workers have demon- 
strated by the use of inhibitors that the cytolytic action 
of glucocorticoid hormones in leukemic cells is nega- 
tively controlled by mono-ADP-ribosylatiun while 
poly-(ADP-ribose)polymerase is not involved [6]. In 
cultured pulmonary endothelial cells ADP-ribosylation 
Corrcs~ondcnce uddrcss: G. Thorgeirsson, Depnrtment of Pharmacol- 
ogy, Univerzity of lcclond, Annih 30, Rcykjavlk, Icclnnd. Fax: 
(354) (I) 680872. 
of actin induced by botulinurn Cz toxin modifies the 
monomeric G-form of actin in such a way that its ability 
to polymerase is inhibited resulting in increased perme- 
ability of the pulmonary artery endothelial monolayer 
[73. While it has been demonstrated that cholera toxin 
increases prostacyclin (PGI?) production in endothelial 
cells [S] no published information is available about the 
possible role of endogenous ADP-ribosylation in endo- 
thelial signal lransduction mechanisms like those in- 
volved in production of PGI?. In chicken spleen mem- 
branes [9] and in platelets [lo] it has recently been dem- 
onstrated that basal adenylyl cyclase activity is en- 
hanced by endogenous ADP-ribosylation of the a-sub- 
unit of the stimulatory GTP-binding protein Gs. The 
implication is that basal adenylyl cyclase activity in 
eukaryotic cells may be controlled via endogenoLls 
ADP-ribosylation. Recently Nowicki and co-workers 
observed that nicotinamide and 3-aminobenzamide at 
high concentrations inhibited inositol phosphate gener- 
ation and Ca’* mobilization in cytotoxic T-cells [1 11. 
The high doses and relative potency of the inhibitors 
suggested involvement of a mono(ADP-ribosylj trans- 
ferase rather than a poly-(ADP-ribosej polymerase [12]. 
Using inhibitors of ADP-ribosylation, we have started 
to investigate the role of this form of modification of 
regulatory proteins on endothelial production of inosi- 
to1 phosphates, release 3f arachidonic acid and the pro- 
duction of PC& in response to various stimuli including 
thrombin, histamine and leukotriene Cd. 
Abbreviations: LAME, L-aginine methyl ester; MIBG, ttzeln-iodo- 
benzylguanidine; MIBA, nlefa-iodobenzylamine; PGI,, prostacyclin. 
Of particular value is the availability of the novel 
inhibitor of cellular monc ADP-ribosylation, nzcta- 
iodo-benzylguanidine (MIBG). It can be used at lower 
concentrations than nicotinamide and L-arginine 
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methyl ester (LAME) and has no effects on poly-(ADP- 
ribose) polymerase activity [5]. 
2. MATERIALS AND METHODS 
[3H]arachidonic ucid, rye-[‘Hlinositol and [SH]6-oxo-PGFI, were 
obtained from Amcrsham international; Morgan’s medium 199, foctal 
calf serum and nntibiotics were from Gibco; collngenase, bovine serum 
albumin, HEPES, LiCl, histamine, lcukotricnc C,, thrombin, nicotin- 
amide and L-argininc methyl ester (LAME) wcrc fr’ram Sigma; anion- 
exchange resin was from Bio-Rnd; tissue culture plates were from 
Nunc; moru-iodo.henzylamine (MIBA) was from Aldrich Chemical, 
Milwaukee, WI; Anti-(6.oxo-PGF,,) antiserum was donated by Dr. 
Michael Dunn, Department of Medicine, Case Western Reserve Uni- 
versity, Cleveland, OH, USA and mrra-iodo-bcnzylguanidinc (MIBG) 
was donated by Dr. L.A. Smets, Department of Experimental Ther- 
apy, The Netherlands Cancer InaitutelAntoni v. Leeuwcnhockhuis, 
Amsterdam, The Netherlands. 
Endothelial cells were cultured from human umbilical veins by the 
method of Jatl? ct al. as previously described [13]. After lxrvesting the 
cells with 0.1% collagennsc digestion, they were seeded on 35 mm 
culture dishes in Morgan’s medium 199 containing 20% foetal calf 
serum and antibiotics (penicillin, 100 units/ml and streptomycin, 100 
@ml). The medium was changed 24 h after seeding the cells and every 
3-4 days therenl’tcr until the cell culture reached confluence. 
2.3. Formation of itzosital phospitares 
Cell cultures that had reached confluence were incubated for 30-36 
h in Morgan’s medium 199 containing 20% dialyzed foetal calf serum 
und 3,uCi ofnryo-[‘HjinositolIml. Before experiments took place, cells 
were washed twice with medium containing 20 mM LiCl. The cells 
were then placed in 0.9 ml of medium, containing 20 mM LiCl with 
inhibitors at the indicated concentrations. Twenty minutes later, 0.1 
ml ofconcentrated agonist was added to reach the intended concentra- 
tion itnd the cells incubated for additional 20 min. The medium was 
then removed for measurement of PC& and 1 ml of ice-cold trichlo- 
roacctic acid (TCA) was added to terminate reactions. Inositol phos- 
photcs were separated as previously described [13] on columns of 
onion-exchange resin and then quantitated by liquid scintillation 
counting. 
2.4. Prostacych prodwrion 
To measure the PG12 production of the cells, the medium was 
subjected to a radioimmunoassny (RIA) for &oxo-prostaglnndin F,,, 
R stable catabolitc of PGI:, as previously described [13]. 
2.5. Amchidonk ucid rclcasc 
Confluent cell cultures were incubntcti for 24 h in Morgan’s medium 
199 containing 20% foetal calf serum, antibiotics and 1 PCi of [31-iYlar- 
achidonic ncid/ml. Before experiments were carried out, cells were 
washed twice with medium contnining 0.1% bovine serum albumin 
and kept in this solution. Twenty minutes later a portion of the me- 
dium was removed and an equal volume of medium containing con- 
centrated agonist added. ATtur an additional 20 min another portion 
oT the medium was removed. Both portions were then counted in a 
scintillation counter for quantitation of released activity. 
3. RESULTS 
The effects of the mono-ADP-ribosylation inhibitor 
MIBG on endothelial inositol phosphate production in 
response to histamine and thrombin are shown in Fig. 
1. The response to histamine is almost totally inhibited 
O%-+ I I 0.03 0.1 0.3 
Inhibltor concentration (mM) 
Fig. 1. Effects of MIBG (filled symbols) and MIBA (open symbols) 
on inositol phosphate generation in response to thrombin (triangles) 
or histamine (circles). The responx is calculated as the increase in 
inositol phosphates as a fraction of the total acid-soluble counts. The 
response without an inhibitor is expressed as 100% for cnch agonist 
and was 3,264 cpm after thrombin stimulation and 3,442 cpm after 
histamine stimulation. 
by MIBG at 0.1 mM whereas the response to thrombin 
is not affected. Figs. 2 and 3 show similar effkcts of 
MIBG on thrombin and histamine-stimulated ara- 
chidonic acid release and prostacyclin production, re- 
spectively. While the responses to histamine are almost 
totally inhibited, the thrombin-mediated responses are 
unaffected except for arachidonic acid release which at 
higher concentrations of MIBG is slightly inhibited. 
Figs. l-3 also show that MIBA, an analog of MIBG 
that does not inhibit cellular ADP-ribosylntion [14], has 
no effects on inositol phosphate generation, or PGIz 
production in response to either histamine or thrombin. 
Arachidonic acid release is also unaffected except at the 
120 : 1 
0 0.03 0.1 0.3 
Inhibitor concenlretion (mM) 
Fig. 2. Ellk~~ of MXBG $lrd symbols) and MIBA [open symbols) 
on arachidonic acid release in response to thrombin (triangles) or 
histamine (circles). The response is calculated as the fraction of incor- 
pornled counti iiurr arc rclcased in rc5-3psiise 3 ~g,oiikis. The X$0?& 
without inhibitor is cxprcsscd as 100% for each agonist and was 10.565 
cpm after lhrombin stimulalion and 19,805 cpm after histamine slim- 
ulation. 
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Fig. 3. The effects of MIBG (filled symbols) and MIBA (open sym- 
bols) on prostacyclin (PG4) production in response to thrombin (tri- 
an&s) or histamine (circles). The response without inhibitor is ex- 
pressed as 100% for each agonist and was 71.4 ng!ml after thrombin 
stimulation and 41.2 @ml after histamine stimulation. 
highest dose of MZBA which inhibits the thrombiu ahd 
histamine responses to a similar extent. 
To further examine the possibility that the elfects of 
MIBG arc unrelated to inhibition of cellular ADP-ri- 
bosylation, the effects of several other known inhibitors 
of ADP-ribosylation on inositol phosphate generation 
were tested. The results are summarized in Table I. 
Guanyltyramine is commonly used as a substrate for 
the arginine-specific ADP-ribosylation of cholera toxin 
[lS], At 3 mM it causes G5% inhibition of histamine- 
mediated inositol phosphate generation, but has negligi- 
ble effects on the response to thrombin and leukotriene 
Cq. Nicotinamide, which at the high concentration used 
(100 mM) is an inhibitor of all ADP-ribosylation reac- 
tions [12], has similar effects. The arginine analog 
LAME at 50 mM inhibits the response to both hista- 
mine and thrombin, but has no effect on inositol phos- 
phate generation in response to leukotriene C,. 
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Fig, 4. The effects of gudnethidinc on inositol phosphate generation 
(circles) and prostacyclin production (triangles) in response to hista- 
mint (open symbols) or thrombin (cioscd symbols). The results are 
calculated and expressed as in Figs. I and 3. 
Tnblc I 
Effects of several inhibitors of ADP-ribosylation on inositol phos- 
phate generation i  response to histamine, thrombin or leukotriene C4 
Stimulus Inhibitor 
Control Nicoti- Guanyl- Argininc 
(no inhibi- nnmide tyramine methyl ester 
tor) (100 mM) (3 mM) (50 mM) 
Histamine (1 I ,uM) 
Thrombin (1 U/ml) 
Lcukotricne C, 
(I50 @ml) 
100 24 35 17 
100 37 xi 8 
100 85 94 99 
The results are expressed as 8 of control for each uponist and are 
calculated as described in the legend to Fig. 1. Each number is the 
mean of duplicate cultures From a represenlative of several ehperi- 
ments that gave essentially the same results. 
Apart from being an inhibitor of cellular ADP-ri- 
bosylation, MIBG is a functional analog of noradre- 
nalin, derived from the neuron blocking agents guan- 
ethidine and bretyllium. We therefore studied the effects 
of isoprenalin and guanethidine on the response to 
thrombin and histamine. Isoprenalin at doses up ‘to 1 
mM had no effect on the response to either agonist (data 
not shown) whereas guanethidine at 1 mM almost to- 
tally inhibited both the inositol phosphate generation 
and prostacyclin production in response to histamine, 
but had little effect on the responses to thrombin (Fig. 
4). 
4. DISCUSSION 
This study demonstrates that inhibitors of ADP-ri- 
bosylation, most notably MIBG the novel inhibitor of 
arginine specific cellular mono(ADP-ribosyl) trans- 
ferase, but also guanyltyramine, nicotinamide and 
LAME, inhibit histamine-induced endothelial produc- 
tion of inositol phosphates, release of arachidonic acid 
and production of PGI?. In contrast, those same re- 
sponses were unaffected by the inhibitors when trig- 
gered by thrombin or leukotriene C4, except for LAME 
inhibiting the response to thrombin. Since LAME is an 
inhibitor of the protease activity of thrombin [16] which 
is necessary for the activation of the thrombin receptor, 
the effects of LAME on cellular responses to thrombin 
probably are unrelated to its activity as an ADP-ribosyl 
transferase inhibitor and are in no contradiction to the 
lack of effects of MIBG and nicotinamide on thrombin- 
induced endothelial responses. MIBG is a functional 
analog of norepinephrine and since it is selectively accu- 
mlltatprl in storage granules of chromaffin tissues and . ..n...*-.. ..- 
chromaflin tissue-related tumors its radio-iodinated e- 
rivative has been used as a tumor-seeking tadio-phar- 
maceutical for diagnosis and treatment of neuro endo- 
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crine tumors [17]. Recently Loesberg and co-workers 
[14] demonstrated that NIBG is an high-affinity sub- 
strate for the cholera toxin-catalyzed transfer of ADP- 
ribose from NAD to arginine-like residues. Further- 
more, they showed that MIBG is a substrate for argin- 
ine specific mono(ADP-ribosyl) transferase which aecu- 
mulates in intact mammalian cells and effectively com- 
petes with intracellular acceptors for endogenous en- 
zymes [6]. It is metabolically stable and does not affect 
endogenous poly(ADP-ribose) polymerase. As sug- 
gested by Loesberg and co-workers, this agent appears 
to be a powerful tool to investigate the physiological 
function of mono(ADP-ribosyl)transferases in various 
cells. However, other effects of this agent on cellular 
functions, although possibly related to its ability to in- 
hibit endogenous mono-ADP-ribosylation may intro- 
duce complexities into interpretation of experiments 
such as those presented in this paper. MIBG has been 
shown to inhibit mitochondrial respiration in several 
cell lines and consequently stimulate glucose consump 
tion and lactic acid production [lS]. It is possible that 
such changes affect inositol phosphate metabolism. 
However, the specificity of the inhibition, limited to the 
histamine responses, speaks against he possibility that 
such general phenomena re responsible for the inhib- 
itory effects of MIBG reported in this paper. 
Since histamine H, receptor antagonists are known to 
inhibit endothelial inositol production and l?G13 pro- 
duction [ 131 the question arises if the inhibitory effects 
of MIBG found in the present study are mediated 
through histamine H, receptor antagonism. Such a 
mechanism is highly improbable. The MIBG analog, 
MIBA, in which an amine group has been substituted 
for the ADP-ribosyl-accepting uanidinc group had no 
effects on the histamine-induced endothelial responses 
thus supporting the notion that ADP-ribosyl trans- 
ferase activity serves a role in those respolises. Further 
support is derived from the effects of the other inhib- 
itors of ADP-ribosylation, nicotinamide, LAME and 
guanyltyramine none of which is known to be a hista- 
mine H, receptor antagonist. 
G-proteins involved in signal transduction arc the 
major natura! substrates ofpertussis- and cholera toxin- 
induced ADP-ribosylation. The latter toxin ADP-ri- 
bosylates arginine in Gs. GTP binding proteins gener- 
ally have been thought to be the most important sub- 
strates of endogenous ADP-ribosyl transferases. How- 
ever, in view of the multitude of unique mono-ADP- 
ribosyl transferases that have been purified it is possible 
that mono-ADP ribosylation plays a role in many dif- 
ferent cellu1r.r functions. Actin is a substrate for argin- 
ine specific ADP-ribosylation induced by clostridial 
toxins [73. A member of the 70 kDa heat shock family 
of stress proteins has been shown to be reversibly ADP- 
ribosylated during glucose starvation of mouse 
hepatoma cells [19]. Several other proteins have been 
found to be ADP-ribosylated in various in vitro prepa- 
rations 111. Studies are presently being carried out in our 
laboratory attempting to identify specific substrates of 
ADP-ribosyl transferases that may be activated during 
exposure of endothelial cells to histamine. 
The selective ffects of inhibitors of ADP-ribosyla- 
tion on the endothelial responses to histamine are of 
particular interest. This suggests interference with spe- 
cific steps in the signal transduction pathway. Jacobson 
and co-workers [20] have recently found differences in 
the protein phosphorylation in human umbilicai vein 
ecdothelial cells stimulated by histamine compared to 
those stimulated with thrombin. In platelets, differences 
in signal transduction between thrombin and histamine 
were also suggested by the finding that antiserum 
against the /3r subunits of G-proteins inhibit the hista- 
mine response but not the thrombin response. Several 
reports have recently been published of different ag- 
onists mediating phospholipid breakdown through dif- 
ferent G-proteins in the same cell type [22-241. We have 
shown that histamine-induced production of inositol 
trisphosphate in human umbilical vein endothelial cells 
is more rapid than that induced by thrombin [13]. We 
have also found that pertussis toxin affects the re- 
sponses to different agonists in different ways. There 
was amplification of both leukotriene C4 induced inosi- 
to1 phosphate production and PGll production, 
whereas the responses to thrombin and aluminium fluo- 
ride were not affected [25]. Finally we have observed 
differences in the calcium dependency of arachidonic 
acid release induced by different agonists. While the 
response to AIF, was strictly calcium dependent, the 
leukotriene C4 induced aracliidonic acid release was cal- 
cium independent [26]. 
The different effects of inhibitors of ADP-ribosyla- 
tion on the responses to histamine compared to throm- 
bin or leukotriene C, fit into this maze of observations 
that suggest hat different agonists employ different sig- 
nal transduction pathways, involving different G-pro- 
teins, a variable role of calcium and possibly a variable 
role of endogenous mono-ADP-ribosylation. 
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